"Unihäiriöiden ja uniongelmien diagnostiikan ja hoidon uranuurtaja. Tutkimusjohtajana toimii professori Markku Partinen ja ylilääkärinä neurologi Gabriele Sved. Helsingin Uniklinikka on Suomen narkolepsiatutkimuskeskus."

During the past decade, Vitalmed Uniklinikka conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Vitalmed Uniklinikka" are "Insomnia Disorder" (2 trials), "Narcolepsy Type 1 (NT1)" (1 trials), "Narcolepsy Type 2 (NT2)" (1 trials), "Narcolepsy With Cataplexy" (1 trials) and "Narcolepsy Without Cataplexy" (1 trials). Many other conditions were trialed in "Vitalmed Uniklinikka" in a lesser frequency.

Most popular intervention types in "Vitalmed Uniklinikka" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Daridorexant" (1 trials), "Daridorexant 10 mg" (1 trials), "Daridorexant 25 mg" (1 trials) and "Daridorexant 50 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vitalmed Uniklinikka" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Vitalmed Uniklinikka". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Vitalmed Uniklinikka, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Vitalmed Uniklinikka, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".